Saydam, G.Haznedaroğlu, I. C.Kaynar, L.Yavuz, A. S.Ali, RıdvanGüvenç, B.Akay, O. M.Başlar, Z.Özbek, U.Sönmez, M.Aydın, D.Pehlivan, M.Undar, B.Dağdaş, S.Ayyıldız, O. M.Uar, B.Dağ, I. M.İlhan, O.2024-08-092024-08-092015-06-010390-6078https://hdl.handle.net/11452/43827Bu çalışma, 11-14, Haziran 2015 tarihlerinde Vienna[Avusturya]’da düzenlenen 20. Congress of European-Hematology-Association Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineHematologyNilotinib results in improved rates of molecular response in Turkish newly diagnosed CML-CP patients: A 24-month updateMeeting Abstract000361204904296695696100